Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-13

Clinical Trial Update: Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial compared a fixed-dose combination of brinzolamide 1% and timolol 0.5% with separate brinzolamide 1% plus timolol 0.5% in open-angle glaucoma or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide 1% (brinzolamide)
  • Brinzolamide 1% / Timolol 0.5% fixed combination (brinzolamide/timolol)
  • Timolol 0.5% (timolol)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2014-03-13